Market Insights Health Medical Technology Medical Devices

Diabetes Care Devices - United States

United States

Revenue in the Diabetes Care Devices market market in the United States is anticipated to attain €10.86bn in 2024.
This revenue is projected to exhibit an annual growth rate (CAGR 2024-2029) of 11.81%, culminating in a market volume of €18.98bn by 2029.
In a global context, the majority of revenue will be generated the in the United States, amounting to €10.86bn in 2024.
The United States is witnessing a surge in innovative diabetes care devices, driven by increasing patient demand for personalized and technology-driven healthcare solutions.

Key regions: Netherlands, Japan, France, Italy, China

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Diabetes Care Devices Market in the United States is witnessing considerable growth, fueled by advancements in technology, increasing prevalence of diabetes, and heightened consumer awareness about effective management solutions for the condition.

Customer preferences: Consumers are increasingly prioritizing personalized diabetes management solutions, leading to a rise in demand for smart insulin pens and continuous glucose monitoring systems that integrate with mobile apps. The growing popularity of telehealth services is enabling patients to access real-time support and education from healthcare professionals. Additionally, there is a notable trend towards community-driven support networks, reflecting a cultural shift towards shared experiences and collective empowerment in managing diabetes effectively.

Trends in the market: In the United States, the Diabetes Care Devices Market is experiencing a surge in demand for smart insulin pens and continuous glucose monitoring systems that seamlessly connect with mobile applications. This trend is fueled by consumers’ desire for personalized diabetes management solutions that enhance their daily lives. Moreover, the rise of telehealth services is transforming patient care by providing real-time support and education from healthcare professionals. These developments are fostering community-driven support networks, emphasizing shared experiences and collective empowerment in diabetes management, which could significantly reshape industry offerings and patient engagement strategies.

Local special circumstances: In the United States, the Diabetes Care Devices Market is shaped by a combination of advanced healthcare infrastructure and a culturally diverse population with varying health literacy levels. The regulatory environment, characterized by stringent FDA guidelines, ensures high-quality devices but can also slow innovation. Additionally, the increasing prevalence of diabetes, particularly in underserved communities, has led to a heightened focus on accessibility and affordability. This landscape drives the demand for user-friendly technology and comprehensive education programs, empowering patients to manage their condition effectively.

Underlying macroeconomic factors: The Diabetes Care Devices Market in the United States is significantly shaped by macroeconomic factors such as rising healthcare expenditures, demographic shifts, and technological advancements. The ongoing increase in national healthcare spending reflects a commitment to improving chronic disease management, thereby boosting demand for innovative diabetes care solutions. Additionally, the economic recovery post-pandemic has led to increased consumer spending on health technologies. Fiscal policies promoting healthcare accessibility further enhance market growth, particularly for underserved populations, while the global emphasis on preventive care aligns with the rising prevalence of diabetes, catalyzing innovation and adoption of advanced diabetes management devices.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.